Intra-arterial thrombolysis within three hours of stroke onset in middle cerebral artery strokes

Neurocritical Care

Volumn 11, Issue 2, 2009, Pages 217-222

  Bourekas, Eric C ^a   Slivka, Andrew ^a   Shah, Rajul ^a,d   Mohammad, Yousef ^a   Slone, H Wayne ^a   Kehagias, Dimitris T ^a,e   Suarez, Jose ^b,f   Sunshine, Jeffrey ^b   Zaidat, Osama O ^b,g   Tarr, Robert ^b   Landis, Dennis M ^b,f   Suri, M Fareed K ^c,h   Qureshi, Adnan I ^c,h  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d St Mary's Hospital   (United States)

^e HYGEIA HOSPITAL   (Greece)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Intra arterial; Middle cerebral artery; Stroke; Thrombolysis; TPA; Treatment

Indexed keywords

ALTEPLASE; HEPARIN; RETEPLASE; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; PRIORITY JOURNAL; RECANALIZATION; STROKE; TREATMENT OUTCOME;

AGED; CEREBRAL ANGIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; ODDS RATIO; PATIENT CARE TEAM; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350571194     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-009-9198-8     Document Type: Article

References (26)

1. BJ Sussman TSP Fitch 1958 Thrombolysis with fibrinolysis in cerebral arterial occlusion JAMA 167 1705 9 1:STN:280:DyaG1c7gs1aksQ%3D%3D
2. GJ del Zoppo RT Higashida AJ Furlan MS Pessin HA Rowley M Gent The PROACT Investigators 1998 PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke Stroke 29 1 4 11 9445320
3. Furlan A, Higashida RT, Wechsler L, et al. for the PROACT Investigators: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA. 1999;282(21):2003-11. doi: 10.1001/jama.282.21.2003.
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group 1995 Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 24 1581 8 10.1056/NEJM199512143332401 10.1056/NEJM199512143332401
5. J Marler BC Tilley M Lu, et al. 2000 Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study Neurology 55 11 1649 55 11113218 1:STN:280:DC%2BD3M%2FnvFSrtA%3D%3D
6. EC Bourekas AP Slivka R Shah RW Tarr J Sunshine J Suarez 2004 Intra-arterial thrombolytic therapy within 3 hours of the onset of stroke Neurosurgery 4 1 39 46 10.1227/01.NEU.0000097197.61376.05 10.1227/01.NEU. 0000097197.61376.05
7. RC Lisboa BD Jovanovic MJ Alberts 2002 Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke Stroke 33 2866 71 10.1161/01.STR.0000038987.62325.14 12468783 10.1161/01.STR.0000038987. 62325.14 1:CAS:528:DC%2BD38XptVSht70%3D (Pubitemid 35462858)
8. G del Zoppo A Ferbert S Otis, et al. 1988 Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study Stroke 19 3 307 13 3354013
9. W Hacke H Zeumer A Ferbert H Bruckman G del Zoppo 1988 Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease Stroke 19 10 1216 22 3176080 1:STN:280:DyaL1M%2FitVWrsQ%3D%3D
10. E Mori M Tabuchi T Yoshida A Yamadori 1988 Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery Stroke 9 7 802 12
11. O Sasaki S Takeuchi T Koike T Koizumi R Tanaka 1995 Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches Neurosurgery 36 2 246 52 10.1097/00006123-199502000-00002 7731503 10.1097/00006123-199502000-00002 1:STN:280:DyaK2M3kvFSmtA%3D%3D
12. J Theron P Courtheoux A Casasco, et al. 1989 Local intraarterial fibrinolysis in the carotid territory AJNR Am J Neuroradiol 10 4 753 65 2505504 1:STN:280:DyaL1MzntFeisg%3D%3D
13. JI Suarez JL Sunshine R Tarr, et al. 1999 Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke Stroke 30 10 2094 100 10512912 1:STN:280:DyaK1MvksVSjtA%3D%3D
14. F Gonner L Remonda H Mattle, et al. 1998 Local intra-arterial thrombolysis in acute stroke Stroke 29 1894 900 9731615 1:STN:280: DyaK1cvgtVensw%3D%3D
15. AI Qureshi M Suri A Nasar, et al. 2005 Thrombolysis for ischemic stroke in the united states: data from national hospital discharge survey 1999-2001 Neurosurgery 57 4 647 54 10.1227/01.NEU.0000175546.62088.D6 16239876 10.1227/01.NEU.0000175546.62088.D6
16. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. for the ATLANTIS Study Investigators. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. JAMA. 1999;82(21):2019-26. doi: 10.1001/jama.282.21.2019.
17. W Hacke M Kaste C Fieschi, et al. 1995 Intravenous thrombolysis with reconmbinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA 274 1017 25 10.1001/jama.274.13.1017 7563451 10.1001/jama.274.13.1017 1:CAS:528: DyaK2MXptFWhur0%3D
18. W Hacke M Kaste C Fieschi, et al. 1998 Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators Lancet 352 1245 51 10.1016/S0140-6736(98)08020-9 9788453 10.1016/S0140-6736(98)08020-9 1:CAS:528:DyaK1cXnt1egtLo%3D (Pubitemid 28470336)
19. Wardlaw J, del Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke (Cochrane review). Cochrane Database of Syst Rev. 2003;(3). doi: 10.1002/14651858.CD000213.
20. Kanter D, Kothari R, Panioloi A, et al. The greater Cincinnati tPA experience after the NINDS trial: does a longer time to treatment within the current 3-hour window reduce efficacy? (Abstract). Presented at 24th Annual American Heart Association International Conference on Stroke and Cerebral Circulation, February 5, 1999; Nashville, TN.
21. S Endo N Kuwayama Y Hirashima A Takuya M Nishijima A Takaku 1998 Results of urgent thrombolysis in patients with major stroke and atherothrombotic occlusion of the cervical internal carotid artery AJNR Am J Neuroradiol 19 1169 75 9672034 1:STN:280:DyaK1czjsFOmtw%3D%3D
22. M Arnold G Schroth K Nedeltchev, et al. 2002 Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion Stroke 33 1828 33 10.1161/01.STR.0000020713.89227.B7 12105361 10.1161/01.STR. 0000020713.89227.B7 (Pubitemid 34761070)
23. R Jahan GR Duckwiler CS Kidwell, et al. 1999 Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up AJNR Am J Neuroradiol 20 1291 9 10472989 1:STN:280: DyaK1MzpvF2lug%3D%3D
24. T Tomsick T Brott W Barsan, et al. 1996 Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy AJNR Am J Neuroradiol 17 79 85 8770253 1:STN:280: DyaK28zms1SktA%3D%3D
25. GJ del Zoppo K Poeck MS Pessin, et al. 1992 Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke Ann Neurol 32 78 86 10.1002/ana.410320113 1642475 10.1002/ana.410320113
26. SM Wolpert H Bruckmann R Greenlee L Wechsler Pessin GJ del Zoppo The rt-PA Acute Stroke Study Group 1993 Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator AJNR Am J Neuroradiol 14 3 13 8427107 1:STN:280:DyaK3s7ltFSktA%3D%3D